BSX vs FSBW · P/E 20, rev $10.65B vs P/E 9.6, rev $99.0M
Boston Scientific Corp (BSX) versus FS Bancorp Inc (FSBW) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
FS Bancorp Inc (FSBW) is a banks - regional company listed on NASDAQ.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported FSBW revenue for 2026-06-30 was $99.0M. Net income was $15.8M. FSBW currently screens at market cap $305.3M and trailing P/E 9.6.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. FSBW currently screens at market cap $305.3M and trailing P/E 9.6.
Not investment advice. Open the BSX and FSBW stock pages for the full models.
Not investment advice.